These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 22204716)
1. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
3. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of S-phase kinase-associated protein 2 predicts poor prognosis of hepatocellular carcinoma. Shin E; Kim SH; Jeong HY; Jang JJ; Lee K APMIS; 2012 May; 120(5):349-57. PubMed ID: 22515289 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617 [TBL] [Abstract][Full Text] [Related]
6. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth. Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Chao Y; Shih YL; Chiu JH; Chau GY; Lui WY; Yang WK; Lee SD; Huang TS Cancer Res; 1998 Mar; 58(5):985-90. PubMed ID: 9500460 [TBL] [Abstract][Full Text] [Related]
8. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068 [TBL] [Abstract][Full Text] [Related]
9. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of Cdk10 in hepatocellular carcinoma. Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270 [TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
13. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732 [TBL] [Abstract][Full Text] [Related]
16. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127 [TBL] [Abstract][Full Text] [Related]
17. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Wang Z; Wei W; Sun CK; Chua MS; So S Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386 [TBL] [Abstract][Full Text] [Related]
18. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis. Yachida S; Imaida K; Yokohira M; Hashimoto N; Suzuki S; Okano K; Wakabayashi H; Maeta H; Suzuki Y Ann Surg Oncol; 2010 Dec; 17(12):3386-93. PubMed ID: 20589433 [TBL] [Abstract][Full Text] [Related]
19. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Qin LF; Ng IO Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219 [TBL] [Abstract][Full Text] [Related]
20. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]